Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.140
+0.040 (3.64%)
Dec 5, 2025, 4:00 PM EST - Market closed

Boundless Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2665---
Enterprise Value
-42-102---
Last Close Price
1.142.90---
PB Ratio
0.230.43---
P/TBV Ratio
0.230.43---
Debt / Equity Ratio
0.450.320.020.080.00
Quick Ratio
9.9318.7012.908.6318.89
Current Ratio
10.1418.9813.278.8019.28
Return on Equity (ROE)
-44.88%-48.21%-52.93%-52.16%-
Return on Assets (ROA)
-24.66%-27.23%-33.13%-30.48%-
Return on Capital (ROIC)
-26.08%-28.53%-35.28%-31.99%-
Return on Capital Employed (ROCE)
-43.20%-37.00%-45.50%-67.20%-23.00%
Earnings Yield
-242.03%-101.08%---
FCF Yield
-206.54%-98.01%---
Buyback Yield / Dilution
-90.73%-1296.71%-10.77%-27.56%-
Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q